Omega Therapeutics Inc (OMGA)
2.27
-0.08
(-3.40%)
USD |
NASDAQ |
Apr 26, 16:00
2.28
+0.01
(+0.44%)
After-Hours: 20:00
Omega Therapeutics Cash from Operations (TTM): -91.51M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -91.51M |
September 30, 2023 | -98.66M |
June 30, 2023 | -100.46M |
March 31, 2023 | -103.28M |
December 31, 2022 | -98.52M |
September 30, 2022 | -90.23M |
June 30, 2022 | -81.90M |
Date | Value |
---|---|
March 31, 2022 | -70.41M |
December 31, 2021 | -57.61M |
September 30, 2021 | -49.95M |
June 30, 2021 | -40.10M |
March 31, 2021 | -30.95M |
December 31, 2020 | -26.13M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-103.28M
Minimum
Mar 2023
-26.13M
Maximum
Dec 2020
-72.28M
Average
-81.90M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
Fate Therapeutics Inc | -132.26M |
Ocular Therapeutix Inc | -70.23M |
AnaptysBio Inc | -120.80M |
Amneal Pharmaceuticals Inc | 345.58M |
Stoke Therapeutics Inc | -81.07M |